1. Medtech Insight
  2. >>Business

Abbott Moves Forward With TriClip G4 TTVR After Successful Advisory Panel

 
• By Reed Miller

After an FDA advisory panel voted in support of Abbott’s PMA for the TriClip G4 transcatheter tricuspid valve repair device, Medtech Insight discussed the panel’s review with Barathi Sethuraman, DVP for clinical affairs for Abbott’s structural heart business.

Triclip transcatheter tricuspid repair device
• Source: Abbott

Abbott is preparing to train centers to treat severe tricuspid valve regurgitation with its TriClip G4 transcatheter edge-to-edge repair device now that US regulatory approval in 2024 is all but assured.

Wall Street analysts expect the US Food and Drug Administration to approve TriClip G4 in

More from Business

More from Medtech Insight